FDA Recalls Blood Pressure Medication Linked to Cancer Risk
The FDA has initiated a blood pressure medication recall due to a potential cancer risk from nitrosamine impurities.
blood pressure medication recall
The FDA has initiated a blood pressure medication recall due to a potential cancer risk from nitrosamine impurities.
